CN111493326A - Enteral nutrition food and preparation method and application thereof - Google Patents
Enteral nutrition food and preparation method and application thereof Download PDFInfo
- Publication number
- CN111493326A CN111493326A CN202010348664.2A CN202010348664A CN111493326A CN 111493326 A CN111493326 A CN 111493326A CN 202010348664 A CN202010348664 A CN 202010348664A CN 111493326 A CN111493326 A CN 111493326A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- puffed
- enteral
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 93
- 235000013305 food Nutrition 0.000 title claims abstract description 69
- 230000035764 nutrition Effects 0.000 title claims description 60
- 238000002360 preparation method Methods 0.000 title abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 108
- 244000068988 Glycine max Species 0.000 claims abstract description 20
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 17
- 239000011707 mineral Substances 0.000 claims abstract description 17
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 16
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 16
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 16
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 16
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 13
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 13
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 13
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 13
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- 239000004475 Arginine Substances 0.000 claims abstract description 12
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 12
- 229930182816 L-glutamine Natural products 0.000 claims abstract description 12
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 12
- -1 compound vitamin Chemical class 0.000 claims abstract description 12
- 239000007787 solid Substances 0.000 claims abstract description 12
- 235000008939 whole milk Nutrition 0.000 claims abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract description 11
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 11
- 235000020279 black tea Nutrition 0.000 claims abstract description 11
- 235000013339 cereals Nutrition 0.000 claims description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- 239000011812 mixed powder Substances 0.000 claims description 18
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 18
- 235000010755 mineral Nutrition 0.000 claims description 16
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 229920001202 Inulin Polymers 0.000 claims description 10
- 239000001506 calcium phosphate Substances 0.000 claims description 10
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 10
- 229940029339 inulin Drugs 0.000 claims description 10
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 10
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 10
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 10
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 9
- 239000002211 L-ascorbic acid Substances 0.000 claims description 9
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- 229960005070 ascorbic acid Drugs 0.000 claims description 9
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 9
- 239000011666 cyanocobalamin Substances 0.000 claims description 9
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 9
- 239000001095 magnesium carbonate Substances 0.000 claims description 9
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 9
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 9
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 9
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 9
- 229960000342 retinol acetate Drugs 0.000 claims description 9
- 235000019173 retinyl acetate Nutrition 0.000 claims description 9
- 239000011770 retinyl acetate Substances 0.000 claims description 9
- 235000019192 riboflavin Nutrition 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 239000002151 riboflavin Substances 0.000 claims description 9
- 229960001471 sodium selenite Drugs 0.000 claims description 9
- 239000011781 sodium selenite Substances 0.000 claims description 9
- 235000015921 sodium selenite Nutrition 0.000 claims description 9
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 9
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 9
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 8
- 235000013325 dietary fiber Nutrition 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 229940042585 tocopherol acetate Drugs 0.000 claims description 8
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 8
- 235000005282 vitamin D3 Nutrition 0.000 claims description 8
- 239000011647 vitamin D3 Substances 0.000 claims description 8
- 229940021056 vitamin d3 Drugs 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229960002104 cyanocobalamin Drugs 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000002682 general surgery Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 235000019197 fats Nutrition 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229940091258 selenium supplement Drugs 0.000 claims description 4
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 235000021329 brown rice Nutrition 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 229920000294 Resistant starch Polymers 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000019895 oat fiber Nutrition 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000021254 resistant starch Nutrition 0.000 claims description 2
- 229920001592 potato starch Polymers 0.000 claims 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 235000004976 Solanum vernei Nutrition 0.000 claims 1
- 241000352057 Solanum vernei Species 0.000 claims 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
- 235000011869 dried fruits Nutrition 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 description 14
- 206010067484 Adverse reaction Diseases 0.000 description 11
- 230000006838 adverse reaction Effects 0.000 description 11
- 230000002980 postoperative effect Effects 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 5
- 240000008790 Musa x paradisiaca Species 0.000 description 5
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 5
- 108010071690 Prealbumin Proteins 0.000 description 5
- 102000007584 Prealbumin Human genes 0.000 description 5
- 102000007544 Whey Proteins Human genes 0.000 description 5
- 108010046377 Whey Proteins Proteins 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 244000017020 Ipomoea batatas Species 0.000 description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000003715 nutritional status Nutrition 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 208000002720 Malnutrition Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000030136 gastric emptying Effects 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 235000020888 liquid diet Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001007 puffing effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- SRFKWQSWMOPVQK-UHFFFAOYSA-K sodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron(2+) Chemical compound [Na+].[Fe+2].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SRFKWQSWMOPVQK-UHFFFAOYSA-K 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- UOMQUZPKALKDCA-UHFFFAOYSA-K 2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron(3+) Chemical compound [Fe+3].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UOMQUZPKALKDCA-UHFFFAOYSA-K 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010007733 Catabolic state Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010049645 Hypercatabolism Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027207 Whipple disease Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000003031 feeding effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000021542 oral nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/12—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
- A23L19/15—Unshaped dry products, e.g. powders, flakes, granules or agglomerates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/26—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by irradiation without heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/161—Puffed cereals, e.g. popcorn or puffed rice
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses an enteral nutritional food and a preparation method and application thereof, the enteral nutritional food comprises 10-40 parts of separated albumen powder, 5-18 parts of freeze-dried fruit powder, 5-20 parts of enzymolysis oat powder, 5-15 parts of MCT powder, 5-18 parts of whole milk powder, 10-30 parts of maltodextrin, 5-18 parts of microwave puffed grains, 3-10 parts of coconut powder, 2-8 parts of instant Ceylon black tea powder, 3-15 parts of solid malt extract, 2-5 parts of low methoxyl pectin, 1-12 parts of fructo-oligosaccharide, L-glutamine 1-5 parts, 0.6-4 parts of arginine, 3-20 parts of soybean oligopeptide, 0.71091-2.41419 parts of compound vitamin and 0.29103-0.52907 parts of compound mineral substance.
Description
Technical Field
The invention relates to a nutritional food, in particular to an enteral nutritional food and a preparation method and application thereof.
Background
For the postoperative patients of general surgery, the gastrointestinal functions of the patients are certain obstacles, and the bodies of the postoperative patients are often in high decomposition and high metabolism states, so that the demand of the bodies on energy is increased, various malnutrition phenomena are easy to occur, and the development and regression of diseases are easily influenced. Therefore, the administration of timely nutritional support and the maintenance of gastrointestinal function is very critical and important for the regulation of body immunity. In recent years, enteral nutrition (intestinal nutrition EN), particularly early enteral nutrition after surgery, has been regarded by clinicians, and it has been found in practice that enteral nutrition given 1 to 2 days after surgery does not have significant complications, and generally only mild abdominal distension, nausea or diarrhea. The reason for this is that enteral nutrition can directly stimulate intestinal mucosa to proliferate, and serve as a protective barrier to prevent intestinal bacteria ectopy; thus, scholars at home and abroad have consistently emphasized the important role of enteral nutrition and have shown that enteral nutrition is used as much as possible as long as the intestinal function is present.
Generally, diseases, inflammations, viral infections, surgical wounds and adverse environments can cause a series of physiological changes of the organism, which are mainly manifested by hypercatabolism, increased energy consumption, negative nitrogen balance and hypoproteinemia, and immune system problems caused by malnutrition frequently occur due to insufficient nutrients ingested by patients due to the increased energy consumption. After operation, the increase of catabolism of the body can aggravate malnutrition, and the body is in an immunosuppression state due to operation trauma; therefore, it is very important to increase the risk of infection due to low immune function after surgery, improve the nutritional status before and after surgery, and recover the immune function of the body.
Generally, enteral nutrition preparation powder is two types of macromolecular compounds and low molecular monomers according to the degree of pre-digestion, and the dosage form of the special medical purpose formula Food (FSMP) is mostly homogenized and whole protein preparation according to the type of the FSMP (food for special medical purpose formula food) described in the literature, "clinical application adverse reaction analysis of special medical purpose formula food in Sichuan province", accounts for 76.35% in total, and may be related to the higher requirement of the non-essential preparation on the gastrointestinal tract digestion function. However, the short-peptide enteral nutrition still causes adverse reactions, presumably due to its high osmotic pressure. In addition, adverse reactions are easy to occur in patients, which are possibly related to the coexistence of multiple diseases and physical weakness of the patients, particularly the functions of the main organs of the old, such as the heart, the liver, the kidney and the like, are declined to different degrees, so that the metabolic process of the enteral nutrition preparation in vivo is influenced. The elderly postoperative patients have reduced gastric acid secretion, decreased gastric emptying rate, poor gastrointestinal local blood circulation, decreased muscular atrophy absorption area, and degraded food absorption and digestion function. Meanwhile, the sensitivity of nerve ending receptors of the old patients is reduced, the reaction capability of tissues and organs to ingested food is obviously reduced, and special medical foods can also cause discomfort of gastrointestinal tracts.
At present, Oral Nutrition Supplements (ONS) are one of important measures for nutrition support, and are effective, noninvasive, and widely applicable to people, and among patients with adverse reactions (such as abdominal distension, nausea, vomiting, diarrhea, greasiness, poor appetite, and the like), the nutrition support mode still accounts for 77.03% with ONS being more, and patients who use nasogastric and nasointestinal tubes for nutrition support treatment account for 19.59% and 3.38% respectively. Meanwhile, researches show that the types of the nutritional preparations are mostly used in the case of adverse reactions, namely the types of the homogenate and the whole protein preparation account for 76.35 percent.
Under the stress conditions of trauma and operation, the organism is in a high catabolic state, and the metabolism in tissue cells is disordered. Under such conditions, the food ingested by the human body cannot only be considered to supplement the nutrients normally required, but rather to adapt and regulate the metabolic disorders within the tissue cells to maintain the normal metabolism of the cells and the normal structure and function of the tissue organs. However, in the prior art, a few nutritional foods for promoting postoperative rehabilitation have single effect and poor effect, so that the recovery period of a patient is long, and an enteral nutritional food with good effect and short recovery time is urgently needed.
Disclosure of Invention
In order to overcome the problems of the prior art, it is a first object of the present invention to provide an enteral nutritional food.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
an enteral nutrition food comprises the following components in parts by weight:
10-40 parts of separated albumen powder, 5-18 parts of freeze-dried fruit powder, 5-20 parts of enzymolysis oat powder, 5-15 parts of MCT powder, 5-18 parts of whole milk powder, 10-30 parts of maltodextrin, 5-18 parts of microwave puffed grains, 3-10 parts of coconut powder, 2-8 parts of instant Ceylon black tea powder, 3-15 parts of solid malt extract, 2-5 parts of low-methoxyl-group pectin, 1-12 parts of fructo-oligosaccharide, 1-5 parts of L-glutamine, 0.6-4 parts of arginine, 3-20 parts of soybean oligopeptide, 0.71091-2.41419 parts of compound vitamin and 0.29103-0.52907 parts of compound mineral substance.
Preferably, the vitamin complex comprises the following components, by weight, 0.001-0.004 parts of retinyl acetate, 0.2-0.4 parts of cholecalciferol, 0.005-0.001 parts of thiamine hydrochloride, 0.0005-0.001 parts of tocopherol acetate, 0.001-0.002 parts of riboflavin, 0.0008-0.0012 parts of pyridoxine hydrochloride, 0.00001-0.00009 parts of cyanocobalamin, 0.5-2 parts of L-ascorbic acid, 0.001-0.002 parts of nicotinamide, 0.001-0.002 parts of nicotinic acid and 0.0006-0.0009 parts of folic acid;
the composite mineral comprises the following components: 0.2 to 0.4 portion of tricalcium phosphate, 0.09 to 0.12 portion of magnesium carbonate, 0.00003 to 0.00007 portion of sodium selenite and 0.001 to 0.009 portion of sodium ferric ethylenediamine tetraacetate.
Preferably, the enteral nutrition food comprises the following components in parts by weight:
15-20 parts of separated albumen powder, 7-14 parts of freeze-dried fruit powder, 7-15 parts of enzymolysis oat powder, 5-10 parts of MCT powder, 5-14 parts of whole milk powder, 13-20 parts of maltodextrin, 5-15 parts of microwave puffed grains, 5-10 parts of coconut powder, 4-11 parts of solid malt extract, soluble dietary fiber, 2-5 parts of low methoxyl pectin, 2-4 parts of instant Ceylon black tea powder, 3-8 parts of fructo-oligosaccharide, 1-3 parts of L-glutamine, 0.8-2 parts of arginine, 4-10 parts of soybean oligopeptide, 0.81332-2.31316 parts of compound vitamin and 0.39104-0.51906 parts of compound mineral substance;
the compound vitamin comprises the following components of 0.002-0.003 part of retinyl acetate, 0.2-0.3 part of cholecalciferol, 0.006-0.001 part of thiamine hydrochloride, 0.0006-0.001 part of tocopherol acetate, 0.001-0.002 part of riboflavin, 0.0010-0.0012 part of pyridoxine hydrochloride, 0.00002-0.00006 part of cyanocobalamin, 0.6-2 parts of L-ascorbic acid, 0.001-0.002 part of nicotinamide, 0.001-0.002 part of nicotinic acid and 0.0007-0.0009 part of folic acid;
the composite mineral comprises the following components: 0.3 to 0.4 portion of tricalcium phosphate, 0.09 to 0.11 portion of magnesium carbonate, 0.00004 to 0.00006 portion of sodium selenite and 0.001 to 0.009 portion of sodium ferric ethylenediamine tetraacetate.
Preferably, the selenium element in the compound mineral can also be provided by 0.05-0.1 part of selenium-enriched yeast.
Preferably, the soluble dietary fiber contained in the low methoxyl pectin and the fructo-oligosaccharide can also be provided by other substances: 3-8 parts of inulin, 1-3 parts of xylo-oligosaccharide, 1-3 parts of soybean oligosaccharide, 1-3 parts of resistant starch, 1-3 parts of resistant dextrin and any two or more of polydextrose.
Preferably, the insoluble dietary fiber contained in the microwave puffed cereal, the enzymatic oat and the freeze-dried fruit powder can also be provided by other substances: 1-2 parts of resistant dextrin, 5-18 parts of oat fiber, 1-5 parts of wheat fiber and 1-5 parts of soybean fiber.
Preferably, the microwave puffed grain is any one or more of puffed rice flour, puffed brown rice flour, puffed purple sweet potato powder and puffed potato powder; the esterification degree of the low methoxyl pectin is less than 50%.
The second purpose of the invention is to provide a preparation method of enteral nutrition food, which comprises the following steps of S1, adding separated albumen powder, freeze-dried fruit powder, enzymolysis oat powder, MCT powder, whole milk powder, maltodextrin, microwave puffed grains, coconut powder, Ceylon instant black tea powder, solid malt extract, low methoxyl pectin, fructo-oligosaccharide, L-glutamine, arginine and soybean oligopeptide into a stirrer together for fully mixing to obtain a mixture;
step S2: crushing the mixture obtained in the step S1 to obtain mixed powder with the particle size of 100-120 meshes;
step S3: sterilizing the mixed powder obtained in step S2;
step S4: spray drying and screening the mixed powder sterilized in the step S3 to obtain mixed powder with the water content of 3-5% and the grain size of less than 100 meshes;
step S5: cooling the mixed powder obtained in the step S4 to normal temperature, and then adding the compound vitamin and the compound mineral into the cooled mixed powder to finally obtain the enteral nutrition food with the mass content of carbohydrate of 45-55%, the mass content of protein of 25-35% and the mass content of fat of 25-30%;
step S6: and (4) filling nitrogen to package the enteral nutrition food obtained in the step (S5) at normal temperature and with the relative humidity of 35-70%.
Preferably, the sterilization manner in step S3 is irradiation of radiation, and the drying conditions in step S4 are: the air inlet temperature is 90-200 ℃, and the air outlet temperature is 60-120 ℃.
A third object of the present invention is to apply enteral nutrition to general surgery patients.
Compared with the prior art, the invention has the following beneficial effects:
(1) according to the invention, by enriching the types of enteral nutrition foods, such as adding microwave puffed grains, enzymolysis oat powder, freeze-dried fruit powder, sugar-free coconut powder, inulin and the like, on one hand, stomach discomfort caused by the change of food sources in a short period of time of a patient is relieved, satiety is enhanced, and the recovery of stomach function is promoted; on the other hand, the purposes of improving the gastrointestinal compliance of patients, enhancing the digestion and absorption functions and improving the nutritional status of the patients so as to reduce the hospitalization time are achieved, and the wound healing time of the patients taking the enteral nutrition food prepared by the invention is found to be at least 2 days shorter than that of the patients taking the common enteral nutrition food in clinic. In addition, the invention also reduces the occurrence of gastrointestinal adverse reactions by adding low methoxyl pectin (the esterification degree is lower than 50 percent) and the bridging effect of multivalent cations and adjusting the proportion of soybean oligopeptide, fructo-oligosaccharide, inulin and the like in the enteral nutrition food, thereby better realizing the enteral nutrition supplement and treatment.
(2) The low methoxyl pectin in the enteral nutrition food disclosed by the invention is combined with free calcium ions decomposed from tricalcium phosphate in the gastric acid environment, so that an ion-combined semi-solidified chyme-shaped gel is formed, the feeding effect of normal food can be simulated, the proper gastric emptying time is ensured, and the common adverse reactions of enteral nutrition preparations such as acid regurgitation, diarrhea and the like are prevented. In addition, the insoluble dietary fibers rich in the natural food raw materials such as the microwave puffed grains, the enzymolysis oat, the freeze-dried fruit powder, the inulin and the like increase the water content and the volume of food, so that the excrement normally passes through the intestine to promote the generation of soft excrement and reduce the postoperative intestinal pressure. In addition, insoluble dietary fibers contained in the microwave puffed grains, the enzymolysis oat, the freeze-dried fruit powder and the inulin increase gastrointestinal viscosity, so that emptying time is prolonged, esophagus reflux and vomiting are prevented, patients can have good satiety and moderate energy density after eating the formula food, and the enteral nutrient substance can meet continuous energy supply for 3-4 hours in the practical application process.
(3) The protein in the invention is separated whey protein, on one hand, the bioavailability of the whey protein is fully exerted, and on the other hand, the immune globulin and the lactoferrin in the separated whey protein have the immune activity and the anti-oxidation property and can improve the immunity of the organism.
(4) The fructo-oligosaccharide and inulin prebiotics of the present invention are resistant to enzymatic digestion in the upper gastrointestinal tract, reach the colon intact and undergo bacterial fermentation, thereby promoting the balance of intestinal microbiota in patients undergoing general surgery.
(5) MCT in the invention is a medium chain triglyceride, which can be absorbed without pancreatic secretion due to small molecular weight, does not need to form celiac particles with other lipid substances during absorption, is not easy to combine with protein, and directly enters liver through portal vein without lymphatic system. In addition, the substance can be hydrolyzed and removed from circulation more quickly, does not affect the level of blood triacylglycerol, has little influence on liver function, greatly improves the tolerance of patients after liver operation, and is suitable for diseases such as fat hydrolysis, chylomicronemia, most of small intestine excision, intestinal lipodystrophy and the like.
(6) The interaction of the compound vitamin and the compound mineral substances in the invention helps the muscle growth and prevents the muscle mass consumption on one hand, and improves the muscle mass recovery on the other hand, promotes the postoperative rehabilitation and reduces the hospitalization time.
(7) The enteral nutrition food prepared by the preparation method ensures the sanitation and comfortable mouthfeel of the enteral nutrition food through mixing, sterilization and sieving, and the compound vitamin and the compound mineral substance are added at normal temperature to prevent the compound microorganism and the compound mineral substance of the enteral nutrition food from being damaged at high temperature and reduce the effects of the compound vitamin and the compound mineral substance; and packaging the enteral nutrition food in a nitrogen-filled mode to obtain loose and porous infusion type liquid diet.
Detailed Description
Freeze-drying fruit powder:
the freeze-dried fruit powder is a mixed powdery substance obtained by freeze-drying any one or more fruits, and the preparation process comprises the following steps:
firstly, selecting fresh fruits, carrying out ultrasonic cleaning, and then sequentially carrying out wall breaking crushing, multi-stage separation, primary concentration, vacuum low-temperature drying, primary crushing and superfine crushing to obtain freeze-dried fruit powder.
The freeze-dried fruit powder obtained by the preparation process does not retain the bioactive components and the nutritive value of fruits, and has the characteristics of good solubility, dispersibility and rehydration property.
Enzymolysis of oat flour:
the preparation process of the substance with β -glucan content of 4.2-6.6% and protein content of 11-15% in the enzymolysis oat powder comprises the following steps:
firstly, oat is peeled, and then sequentially subjected to microwave enzyme deactivation, enzymolysis, centrifugal separation, precipitate drying and superfine grinding to obtain enzyme-hydrolyzed oat powder.
The enzymolysis oat flour obtained by the preparation process has the characteristics of quick rehydration, good solubility and easy digestion and absorption.
Soybean oligopeptide:
the soybean oligopeptide disclosed by the invention has the protein content of 86.98%, the fat content of 0.04%, the water content of 4.73% and the ash content of 5.08%.
Puffing grains by microwave:
the microwave puffed grain in the invention is any one or more of puffed rice flour, puffed brown rice flour, puffed purple sweet potato powder and puffed potato powder. The instant nutrient has the characteristics of excellent flavor, quick rehydration and high retention of instant nutrient components, and the preparation process comprises the following steps:
the microwave puffed grain is obtained by sequentially carrying out cleaning, cooking, softening treatment, pulping, colloid mill refining and homogenizing, roller drying or microwave puffing and secondary drying on the grain.
MCT:
The MCT in the present invention are medium chain triglycerides, typically derived from rice oil, olive oil, tea oil, linseed oil, coconut oil.
Examples
The technical solution of the present invention will be further clearly and completely described with reference to the following examples, wherein the raw materials used in the examples of the present invention are all commercially available.
Example 1
An enteral nutrition food comprises the following components in parts by weight:
10 parts of separated albumen powder, 5 parts of freeze-dried banana powder, 5 parts of enzymolysis oat powder, 5 parts of MCT powder, 5 parts of full cream milk powder, 10 parts of maltodextrin, 5 parts of microwave puffed grain, 3 parts of coconut powder, 2 parts of Ceylon instant black tea powder, 3 parts of solid malt extract, 2 parts of low methoxyl pectin, 1 part of fructo-oligosaccharide, 1 part of L-glutamine, 0.6 part of arginine, 3 parts of soybean oligopeptide, 0.001 part of retinyl acetate, 0.2 part of cholecalciferol, 0.005 part of thiamine hydrochloride, 0.0005 part of tocopheryl acetate, 0.001 part of riboflavin, 0.0008 part of pyridoxine hydrochloride, 0.00001 part of cyanocobalamine, 0.5 part of L-ascorbic acid, 0.001 part of nicotinamide, 0.001 part of nicotinic acid, 0.0006 part of folic acid, 0.2 part of tricalcium phosphate, 0.09 part of magnesium carbonate, 0.00003 part of sodium selenite and 0.001 part of sodium iron ethylenediaminetetraacetate.
The preparation method specifically comprises the following preparation steps:
step 1, feeding 10 parts of separated albumen powder, 5 parts of freeze-dried banana powder, 5 parts of enzymolysis oat powder, 5 parts of MCT powder, 5 parts of whole milk powder, 10 parts of maltodextrin, 5 parts of microwave puffed grain, 3 parts of coconut powder, 2 parts of instant Ceylon black tea powder, 3 parts of solid malt extract, 2 parts of low-methoxyl-group pectin, 1 part of fructo-oligosaccharide, 1 part of L-glutamine, 0.6 part of arginine and 3 parts of soybean oligopeptide into a V-shaped mixer, and fully mixing in the V-shaped mixer to obtain a mixture.
Step 2: and (3) feeding the mixture obtained in the step (1) into a pulverizer, and pulverizing the mixture into 120-mesh mixed powder with the particle size of 100-.
And step 3: and (3) sterilizing the mixed powder obtained in the step (2) by using 5-10kGy of irradiation rays.
And 4, step 4: spray-drying the mixed powder sterilized in the step (3) by adopting a pressure type spray dryer device and screening the powder to obtain the mixed powder with the water content of 3-5% and the particle size of less than 100 meshes, wherein the spray-drying conditions are as follows: the air inlet temperature is 90-200 ℃, and the air outlet temperature is 60-120 ℃.
And 5, cooling the mixed powder obtained in the step 4 to normal temperature, and then adding 0.001 part of retinyl acetate, 0.2 part of cholecalciferol, 0.005 part of thiamine hydrochloride, 0.0005 part of tocopherol acetate, 0.001 part of riboflavin, 0.0008 part of pyridoxine hydrochloride, 0.00001 part of cyanocobalamin, 0.5 part of L-ascorbic acid, 0.001 part of nicotinamide, 0.001 part of nicotinic acid, 0.0006 part of folic acid, 0.2 part of tricalcium phosphate, 0.09 part of magnesium carbonate, 0.00003 part of sodium selenite and 0.001 part of sodium iron ethylenediaminetetraacetate into the cooled mixed powder to finally obtain the enteral nutrition food with the mass content of carbohydrate of 45-55%, the mass content of protein of 25-35% and the mass content of fat of 25-30%.
Step 6: and (5) filling nitrogen into the enteral nutrition food obtained in the step (5) under the conditions of normal temperature and relative humidity of 35-70%, and packaging to obtain the enteral nutrition food which is loose, porous, strong in water solubility, rich in taste and sufficient in nutrition and is mixed with powdery brewing type liquid diet.
Example 2
An enteral nutrition food comprises the following components in parts by weight:
18 parts of separated albumen powder, 12 parts of freeze-dried banana powder, 12 parts of enzymolysis oat powder, 10 parts of MCT powder, 6 parts of full cream milk powder, 15 parts of maltodextrin, 5 parts of solid malt extract, 5 parts of low methoxyl pectin, 8 parts of fructo-oligosaccharide, 6 parts of puffed purple sweet potato powder, 5 parts of coconut powder, 2.5 parts of Ceylon instant black tea powder, 2 parts of L-glutamine, 1.5 parts of arginine, 8 parts of soybean oligopeptide, 0.003 part of retinyl acetate, 0.2 part of cholecalciferol, 0.001 part of thiamine hydrochloride, 0.001 part of tocopherol acetate, 0.002 part of riboflavin, 0.0012 part of pyridoxine hydrochloride, 0.00006 part of cyanocobalamin, 2 parts of L-ascorbic acid, 0.002 part of nicotinamide, 0.002 part of nicotinic acid, 0.0009 part of folic acid, 0.3 part of tricalcium phosphate, 0.09 part of magnesium carbonate, 0.00004 part of sodium selenite and 0.009 part of ferric ethylene diamine tetraacetate.
The preparation method of the enteral nutrition food was carried out according to the preparation procedure of the enteral nutrition food in example 1.
Example 3
An enteral nutrition food comprises the following components in parts by weight:
40 parts of separated albumen powder, 18 parts of freeze-dried banana powder, 20 parts of enzymolysis oat powder, 15 parts of MCT powder, 18 parts of full cream milk powder, 30 parts of maltodextrin, 18 parts of puffed purple sweet potato powder, 10 parts of coconut powder, 8 parts of Ceylon instant black tea powder, 15 parts of solid malt extract, 5 parts of low methoxyl pectin, 12 parts of fructo-oligosaccharide, 5 parts of L-glutamine, 4 parts of arginine, 20 parts of soybean oligopeptide, 0.004 part of retinyl acetate, 0.4 part of cholecalciferol, 0.001 part of thiamine hydrochloride, 0.001 part of tocopherol acetate, 0.002 part of riboflavin, 0.0012 part of pyridoxine hydrochloride, 0.00009 part of cyanocobalamine, 2 parts of L-ascorbic acid, 0.002 part of nicotinamide, 0.002 part of nicotinic acid, 0.0009 part of folic acid, 0.4 part of tricalcium phosphate, 0.12 part of magnesium carbonate, 0.00007 part of sodium selenite and 0.009 part of sodium ethylene diamine tetraacetate.
The preparation method of the enteral nutrition food was carried out according to the preparation procedure of the enteral nutrition food in example 1.
Example 4
An enteral nutrition food comprises the following components in parts by weight:
22 parts of isolated whey protein powder, 10 parts of whole milk powder, 8 parts of soybean oligopeptide, 10 parts of MCT powder, 15 parts of freeze-dried banana powder, 12 parts of enzymolysis oat powder, 8 parts of maltodextrin, 4 parts of solid malt extract, 3 parts of low methoxyl pectin, 3 parts of fructo-oligosaccharide, 2 parts of inulin, L-glutamine 2 parts, 1.5 parts of arginine, 0.003 part of retinyl acetate, 0.001 part of thiamine hydrochloride, 0.001 part of tocopherol acetate, 0.002 part of riboflavin, 0.0012 part of pyridoxine hydrochloride, 0.00006 part of cyanocobalamine, 2 parts of L-ascorbic acid, 0.002 part of nicotinamide, 0.002 part of nicotinic acid, 0.0009 part of folic acid, 0.3 part of tricalcium phosphate, 0.09 part of magnesium carbonate, 0.00004 part of sodium selenite, 0.009 part of ferric sodium ethylenediamine tetraacetic acid and 0.2 part of calcium.
The preparation method of the enteral nutrition food was carried out according to the preparation procedure of the enteral nutrition food in example 1.
Example 5
The enteral nutrient prepared in example 4 was applied to patients who were subjected to general surgery and studied.
Study subjects: 100 patients who received laparoscopic gastric cancer surgery in 2018 to 2019, month 7, 43 men and 57 women, age 18-70, and average age 40.8 ± 5.3. In addition, patients were subjected to a nutritional risk screening score (NRS score) according to the NRS-2002 scoring sheet recommended by the European Nutrition society. The NRS score is more than or equal to 3, the nutrition risk is considered to be positive, meanwhile, the corresponding laparoscopic surgery treatment is carried out according to the tumor position of the patients, and the treatment intervention of the two groups of patients is completed by the same group of doctors.
The nutrition treatment method comprises the following steps:
1. 100 patients were randomized into experimental (n-50) and control (n-50) groups, with no statistical significance for sex ratio, age, mode of surgery, and differences in preoperative nutritional status (P value > 0.05).
2. The patients in the experimental group and the control group were subjected to nutritional supplementation, wherein the nutritional formulation used in the experimental group was the enteral nutritional food prepared in example 4, and the nutritional formulation used in the control group was an equal-protein energy food composed of whey protein and maltodextrin.
Experimental groups:
nutritional support protocol for preoperative experimental groups: 900ml of the enteral nutrition food prepared in example 4 was orally taken after fasting one day before surgery as a nutritional support before surgery.
Postoperative experimental group nutritional support protocol enteral nutritional food prepared in example 4 was administered as nutritional support (1/2 for which the body normally requires energy) on the day of surgery, × 2 times of the mixed solution of enteral nutritional food prepared in example 4 (82g powder +300 water) was administered on day 1 after surgery, the mixed solution was increased to × 3 times on day 2 after surgery, (82g powder +300 water) × 4 times of the mixed solution was administered on day 3 after surgery while instructing the patient to start voluntary drinking water and a small amount of liquid food, the same parenteral nutritional support was administered on days 4, 5 and 3 after surgery, and half-fluid diet and regular diet were gradually changed on day 4.
Control group:
preoperative and postoperative nutrition support regimens: the patients with positive nutritional risk in the control group are given foods with equal protein energy, and the energy and the nitrogen amount obtained by the two groups of patients at the same time are not obviously different.
The observation indexes comprise nutrition indexes of 1 day before operation, 3 days after operation and 5 days after operation of a comparison experiment group and a control group, namely body mass index (BMI index), albumin (A L B) and Prealbumin (PA), immune function indexes of lymphocyte count (L Y), leukocyte count (WBC), C-reactive protein (CRP, serum immunoglobulin IgA and IgG), and gastrointestinal tract recovery condition, operation complication and gastrointestinal intolerance occurrence condition (gastroesophageal acid regurgitation, diarrhea, abdominal distension and hypodynamia) are observed at the same time.
The experimental results are as follows:
TABLE 1.100 nutritional index for perioperative period of patients
TABLE 2.100 patients' perioperative period different treatment immune index
TABLE 3.100 patients' perioperative period different nutritherapy wound healing index
Group of | n (human) | Show effect | Recovery method | Invalidation | Effective rate (%) | Time to wound healing |
Experimental group | 50 | 21 | 28 | 1 | 98 | 6.5±2.5 |
Control group | 50 | 15 | 19 | 16 | 68** | 8.5±3** |
Table 4.00 patients' incidence of adverse reactions in perioperative period by different nutrition therapy
Adverse reaction | Experimental group | Control group | p value |
Counter acid | 3 | 17 | <0.01 |
Abdominal distention | 5 | 13 | <0.01 |
Diarrhea (diarrhea) | 3 | 19 | <0.01 |
Debilitation | 7 | 26 | <0.01 |
Note: p <0.05, p <0.01, with significant differences below a p value of 0.05;
perioperative period is preoperative + postoperative.
As seen from tables 1 and 2, the nutritional indices: the BMI index and the albumin nutrition index of two groups of patients 1 day before operation are compared, and the difference has no statistical significance (p value is more than 0.05); but the experimental group had higher prealbumin levels than the control group and the difference was statistically significant (p-value < 0.05); both groups of patients had increased albumin and prealbumin levels compared to the previous but the difference was not statistically significant on day 3 post-surgery (p-value > 0.05); on the 5 th day after operation, the albumin and prealbumin levels of the two groups of patients are obviously increased compared with those before operation, and the increase of the albumin level of the experimental group has statistical significance compared with the difference of the control group (the p value is less than 0.05); the BMI index changes at each time interval, and the difference has no statistical significance.
As can be seen from table 3, the effective rate of wound healing in the experimental group was significantly higher than that in the control group (p-value <0.05), and the healing time was significantly lower than that in the control group (p-value < 0.05). According to table 4, the incidence of adverse reactions in the experimental group was significantly lower than that in the control group (p-value <0.01), and it was concluded that the enteral nutritional food prepared according to the present invention contributes to the wound healing of the patients who were operated, and can significantly prevent the occurrence of gastrointestinal distress in the patients.
In summary, the present invention solves the technical deficiencies of the prior art. According to the invention, by enriching the types of enteral nutrition foods, such as adding microwave puffed grains, enzymolysis oat powder, freeze-dried fruit powder, sugar-free coconut powder, inulin and the like, on one hand, stomach discomfort caused by the change of food sources in a short period of time of a patient is relieved, satiety is enhanced, and the recovery of stomach function is promoted; on the other hand, the gastrointestinal compliance of the patient is improved, the digestion and absorption functions are enhanced, and the nutritional status of the patient is improved, so that the aim of reducing the hospitalization time is fulfilled. In addition, the invention also reduces the occurrence of gastrointestinal adverse reactions by adding low methoxyl pectin (the esterification degree is lower than 50 percent) and the bridging effect of multivalent cations and adjusting the proportion of soybean oligopeptide, fructo-oligosaccharide, inulin and the like in the enteral nutrition food, thereby better realizing the enteral nutrition supplement and treatment.
The foregoing is only a partial embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (10)
1. An enteral nutrition food is characterized by comprising the following components in parts by weight:
10-40 parts of separated albumen powder, 5-18 parts of freeze-dried fruit powder, 5-20 parts of enzymolysis oat powder, 5-15 parts of MCT powder, 5-18 parts of whole milk powder, 10-30 parts of maltodextrin, 5-18 parts of microwave puffed grains, 3-10 parts of coconut powder, 2-8 parts of instant Ceylon black tea powder, 3-15 parts of solid malt extract, 2-5 parts of low-methoxyl-group pectin, 1-12 parts of fructo-oligosaccharide, 1-5 parts of L-glutamine, 0.6-4 parts of arginine, 3-20 parts of soybean oligopeptide, 0.71091-2.41419 parts of compound vitamin and 0.29103-0.52907 parts of compound mineral substance.
2. The enteral nutritional food according to claim 1, wherein the multivitamins are composed of, by weight, 0.001-0.004 parts of retinyl acetate, 0.2-0.4 parts of cholecalciferol, 0.005-0.001 parts of thiamine hydrochloride, 0.0005-0.001 parts of tocopherol acetate, 0.001-0.002 parts of riboflavin, 0.0008-0.0012 parts of pyridoxine hydrochloride, 0.00001-0.00009 parts of cyanocobalamin, 0.5-2 parts of L-ascorbic acid, 0.001-0.002 parts of niacinamide, 0.001-0.002 parts of nicotinic acid, 0.0006-0.0009 parts of folic acid;
the composite mineral comprises the following components: 0.2 to 0.4 portion of tricalcium phosphate, 0.09 to 0.12 portion of magnesium carbonate, 0.00003 to 0.00007 portion of sodium selenite and 0.001 to 0.009 portion of sodium ferric ethylenediamine tetraacetate.
3. The enteral nutritional food according to claim 2, which comprises the following components in parts by weight:
15-20 parts of separated albumen powder, 7-14 parts of freeze-dried fruit powder, 7-15 parts of enzymolysis oat powder, 5-10 parts of MCT powder, 5-14 parts of whole milk powder, 13-20 parts of maltodextrin, 5-15 parts of microwave puffed grains, 5-10 parts of coconut powder, 4-11 parts of solid malt extract, soluble dietary fiber, 2-5 parts of low methoxyl pectin, 2-4 parts of instant Ceylon black tea powder, 3-8 parts of fructo-oligosaccharide, 1-3 parts of L-glutamine, 0.8-2 parts of arginine, 4-10 parts of soybean oligopeptide, 0.81332-2.31316 parts of compound vitamin and 0.39104-0.51906 parts of compound mineral substance;
the compound vitamin comprises the following components of 0.002-0.003 part of retinyl acetate, 0.2-0.3 part of cholecalciferol, 0.006-0.001 part of thiamine hydrochloride, 0.0006-0.001 part of tocopherol acetate, 0.001-0.002 part of riboflavin, 0.0010-0.0012 part of pyridoxine hydrochloride, 0.00002-0.00006 part of cyanocobalamin, 0.6-2 parts of L-ascorbic acid, 0.001-0.002 part of nicotinamide, 0.001-0.002 part of nicotinic acid and 0.0007-0.0009 part of folic acid;
the composite mineral comprises the following components: 0.3 to 0.4 portion of tricalcium phosphate, 0.09 to 0.11 portion of magnesium carbonate, 0.00004 to 0.00006 portion of sodium selenite and 0.001 to 0.009 portion of sodium ferric ethylenediamine tetraacetate.
4. An enteral nutritional food according to any one of claims 1 to 3, wherein the selenium in the complex minerals is also provided by 0.05 to 0.1 parts of selenium enriched yeast.
5. An enteral nutritional food according to any one of claims 1 to 3 wherein the soluble dietary fibre contained in the low methoxyl pectin and fructo-oligosaccharides is provided by other means: 3-8 parts of inulin, 1-3 parts of xylo-oligosaccharide, 1-3 parts of soybean oligosaccharide, 1-3 parts of resistant starch, 1-3 parts of resistant dextrin and any two or more of polydextrose.
6. An enteral nutritional food according to any one of claims 1 to 3 wherein the insoluble dietary fibre contained in the microwave puffed cereal, enzymatically digested oat, freeze dried fruit powder is further provided by other means: 1-2 parts of resistant dextrin, 5-18 parts of oat fiber, 1-5 parts of wheat fiber and 1-5 parts of soybean fiber.
7. An enteral nutritional food according to any one of claims 1 to 3 wherein the microwave puffed cereal is any one or more of puffed rice flour, puffed brown rice flour, puffed purple potato flour, puffed potato flour; the esterification degree of the low methoxyl pectin is less than 50%.
8. A method for preparing an enteral nutritional food according to any one of claims 1 to 7, comprising the steps of:
step S1, adding the separated albumen powder, the freeze-dried fruit powder, the enzymolysis oat powder, the MCT powder, the whole milk powder, the maltodextrin, the microwave puffed grain, the coconut powder, the stannum instant black tea powder, the solid malt extract, the low methoxyl pectin, the fructo-oligosaccharide, L-glutamine, the arginine and the soybean oligopeptide into a stirrer together for fully mixing to obtain a mixture;
step S2: crushing the mixture obtained in the step S1 to obtain mixed powder with the particle size of 100-120 meshes;
step S3: sterilizing the mixed powder obtained in step S2;
step S4: spray drying and screening the mixed powder sterilized in the step S3 to obtain mixed powder with the water content of 3-5% and the grain size of less than 100 meshes;
step S5: cooling the mixed powder obtained in the step S4 to normal temperature, and then adding the compound vitamin and the compound mineral into the cooled mixed powder to finally obtain the enteral nutrition food with the mass content of carbohydrate of 45-55%, the mass content of protein of 25-35% and the mass content of fat of 25-30%;
step S6: and (4) filling nitrogen to package the enteral nutrition food obtained in the step (S5) at normal temperature and with the relative humidity of 35-70%.
9. The method of claim 8, wherein the sterilization in step S3 is irradiation, and the drying conditions in step S4 are: the air inlet temperature is 90-200 ℃, and the air outlet temperature is 60-120 ℃.
10. Use of an enteral nutritional product according to any one of claims 1 to 7 in general surgery patients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010348664.2A CN111493326A (en) | 2020-04-28 | 2020-04-28 | Enteral nutrition food and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010348664.2A CN111493326A (en) | 2020-04-28 | 2020-04-28 | Enteral nutrition food and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111493326A true CN111493326A (en) | 2020-08-07 |
Family
ID=71878195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010348664.2A Pending CN111493326A (en) | 2020-04-28 | 2020-04-28 | Enteral nutrition food and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111493326A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112120200A (en) * | 2020-08-27 | 2020-12-25 | 李民健 | Composite edible mushroom instant soup base |
CN112471401A (en) * | 2020-10-26 | 2021-03-12 | 广东省农业科学院蚕业与农产品加工研究所 | Processing method for improving mixing uniformity of micronutrients in nutritional meal replacement food |
CN112890179A (en) * | 2021-03-01 | 2021-06-04 | 成都尚医信息科技有限公司 | Semi-solidified nutrient for solving enteral nutrition intolerance and preparation method thereof |
CN114711374A (en) * | 2022-04-14 | 2022-07-08 | 湖南达侑科技有限公司 | Composite nutrient powder of ferment fibre and its preparation method |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187334B1 (en) * | 1998-09-09 | 2001-02-13 | Kewpie Kabushiki Kaisha | Foods for preventing vomiting |
CN101516402A (en) * | 2006-09-13 | 2009-08-26 | En大塚制药株式会社 | Gel type enteric nutrient |
CN103974723A (en) * | 2012-07-09 | 2014-08-06 | 丘比株式会社 | Aqueous pectin solution |
CN107518411A (en) * | 2017-01-13 | 2017-12-29 | 江苏西宏生物医药有限公司 | A kind of anti-diarrhea enteral nutrition composition |
CN107616981A (en) * | 2017-01-13 | 2018-01-23 | 江苏西宏生物医药有限公司 | A kind of pectin solution for being thickened for Elental and promoting postoperative reparation |
CN108703363A (en) * | 2018-05-03 | 2018-10-26 | 江苏所罗门兄弟医学科技有限公司 | A kind of nutrient powder with antiemetic mouthfeel that tumor patient is applicable |
CN108771220A (en) * | 2018-06-11 | 2018-11-09 | 山东中医药大学 | A kind of full nutrition companion's meal powder of tumor patient |
CN109007794A (en) * | 2018-06-11 | 2018-12-18 | 河北健素临床营养有限公司 | Increase the wholefood of enteron aisle tolerance |
CN109601981A (en) * | 2018-12-10 | 2019-04-12 | 武汉轻工大学 | It is a kind of suitable for premature labor and nutrition spy's dietary seafood of low birth weight infant and preparation method thereof |
CN110226741A (en) * | 2019-06-20 | 2019-09-13 | 上海奥医生物医药科技有限公司 | A kind of ulcerative colitis tailored version clinical nutrition formula and preparation method thereof |
CN110800904A (en) * | 2018-08-06 | 2020-02-18 | 丰宁平安高科实业有限公司 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
-
2020
- 2020-04-28 CN CN202010348664.2A patent/CN111493326A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187334B1 (en) * | 1998-09-09 | 2001-02-13 | Kewpie Kabushiki Kaisha | Foods for preventing vomiting |
CN101516402A (en) * | 2006-09-13 | 2009-08-26 | En大塚制药株式会社 | Gel type enteric nutrient |
CN103974723A (en) * | 2012-07-09 | 2014-08-06 | 丘比株式会社 | Aqueous pectin solution |
CN107518411A (en) * | 2017-01-13 | 2017-12-29 | 江苏西宏生物医药有限公司 | A kind of anti-diarrhea enteral nutrition composition |
CN107616981A (en) * | 2017-01-13 | 2018-01-23 | 江苏西宏生物医药有限公司 | A kind of pectin solution for being thickened for Elental and promoting postoperative reparation |
CN108703363A (en) * | 2018-05-03 | 2018-10-26 | 江苏所罗门兄弟医学科技有限公司 | A kind of nutrient powder with antiemetic mouthfeel that tumor patient is applicable |
CN108771220A (en) * | 2018-06-11 | 2018-11-09 | 山东中医药大学 | A kind of full nutrition companion's meal powder of tumor patient |
CN109007794A (en) * | 2018-06-11 | 2018-12-18 | 河北健素临床营养有限公司 | Increase the wholefood of enteron aisle tolerance |
CN110800904A (en) * | 2018-08-06 | 2020-02-18 | 丰宁平安高科实业有限公司 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
CN109601981A (en) * | 2018-12-10 | 2019-04-12 | 武汉轻工大学 | It is a kind of suitable for premature labor and nutrition spy's dietary seafood of low birth weight infant and preparation method thereof |
CN110226741A (en) * | 2019-06-20 | 2019-09-13 | 上海奥医生物医药科技有限公司 | A kind of ulcerative colitis tailored version clinical nutrition formula and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
王兴华: "精氨酸联合谷氨酰胺肠内营养支持对老年食管癌患者术后胃肠功能及肺部感染发生率的影响", 《医学理论与实践》 * |
苏娅等: "微波膨化谷物食品的工艺研究", 《郑州粮食学院学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112120200A (en) * | 2020-08-27 | 2020-12-25 | 李民健 | Composite edible mushroom instant soup base |
CN112471401A (en) * | 2020-10-26 | 2021-03-12 | 广东省农业科学院蚕业与农产品加工研究所 | Processing method for improving mixing uniformity of micronutrients in nutritional meal replacement food |
CN112890179A (en) * | 2021-03-01 | 2021-06-04 | 成都尚医信息科技有限公司 | Semi-solidified nutrient for solving enteral nutrition intolerance and preparation method thereof |
CN114711374A (en) * | 2022-04-14 | 2022-07-08 | 湖南达侑科技有限公司 | Composite nutrient powder of ferment fibre and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108112996B (en) | Nutritional composition for controlling hyperglycemia and improving immunity of type 2 diabetes mellitus people | |
CN111493326A (en) | Enteral nutrition food and preparation method and application thereof | |
CA2449059C (en) | Polymer controlled induced viscosity fiber system and uses thereof | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
CN110771880A (en) | Blood sugar-reducing quinoa meal replacement powder and preparation process thereof | |
CN110574915A (en) | high-fiber low-calorie high-protein nutritional weight-losing meal replacement product | |
CN106722206A (en) | A kind of composition for alleviating alimentary canal malaise symptoms and/or emotional stress and products thereof | |
CN104605353A (en) | Formula food suitable for being eaten by tumor patients after operation and preparation method of formula food | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN107467462A (en) | A kind of generation meal solid beverage for contributing to fat-reducing and preparation method thereof | |
CN106690331A (en) | Kelp dietary fiber granules and preparation method thereof | |
CN106723087A (en) | A kind of tablet containing kelp dietary fiber and preparation method thereof | |
CN108685100A (en) | A kind of compound small peptide powder formula and preparation method thereof | |
CN105815514A (en) | Weight-losing quinoa milk tea | |
CN104172191A (en) | Total-nutrition formula food for treating atherosclerosis | |
CN106387593A (en) | Protein dietary fiber solid beverage | |
CN111543605A (en) | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity | |
CN112385843A (en) | Balanced nutrition powder containing composite prebiotics and preparation method thereof | |
CN108576827A (en) | Peri-operation period nutraceutical | |
CN112167639A (en) | Composition for bidirectionally regulating morning-onset intestinal fluid balance, preparation method and application thereof | |
CN106805252A (en) | A kind of fish small peptide and its application in nutrition fortifier | |
CN115500508A (en) | Composition for preventing sugar and reducing fat and preparation method thereof | |
CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof | |
CN116076704B (en) | High-energy-density high-fiber-content homogenized food and preparation method thereof | |
CN113575960B (en) | Erythritol digestive system regulating weight-losing meal replacement powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |